Diffuse follicle center lymphoma, lymph nodes of inguinal region and lower limb
ICD-10 C82.55 is a billable code used to indicate a diagnosis of diffuse follicle center lymphoma, lymph nodes of inguinal region and lower limb.
Diffuse follicle center lymphoma (DFCL) is a subtype of non-Hodgkin lymphoma characterized by the proliferation of neoplastic B-cells within the follicle center of lymphoid tissue. This specific code pertains to cases where the lymphoma is localized to the lymph nodes of the inguinal region and lower limb. Clinically, patients may present with painless lymphadenopathy, often accompanied by systemic B-symptoms such as fever, night sweats, and unexplained weight loss. The diagnosis is typically confirmed through histopathological examination of lymph node biopsies, which reveal a diffuse pattern of follicle center cell proliferation. Staging of the disease is crucial for determining prognosis and treatment, with the Ann Arbor staging system commonly employed. Treatment protocols may include chemotherapy, immunotherapy, and in some cases, radiation therapy, depending on the stage and overall health of the patient. Regular follow-up is essential to monitor for disease progression or recurrence.
Detailed clinical notes on patient history, physical examination findings, and treatment plans.
Diagnosis and management of lymphoma, staging assessments, and treatment response evaluations.
Ensure accurate documentation of histopathological findings and treatment regimens.
Comprehensive reports on biopsy results, including histological classification and staging.
Evaluation of lymph node biopsies for lymphoma diagnosis.
Clear communication of findings to the treating physician for accurate coding.
Used when a biopsy is performed to confirm lymphoma diagnosis.
Pathology report detailing histological findings.
Pathologists must ensure accurate classification of lymphoma subtype.
Common symptoms include painless swelling of lymph nodes, fever, night sweats, and unexplained weight loss, known as B-symptoms.
